To include your compound in the COVID-19 Resource Center, submit it here.

BMY misses Street EPS estimate

Bristol-Myers Squibb (BMY) reported second quarter EPS of $0.23, missing the Street consensus by

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE